Arch Therapeutics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
ARTH Over the counter 3841 https://www.archtherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arch Therapeutics Inc

Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY - Oct 7th, 2019 3:50 pm
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment Conference - Sep 3rd, 2019 11:50 am
Arch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5™ Topical Hemostat - Aug 5th, 2019 11:50 am
Arch Therapeutics to Provide Corporate Update at the 9th Annual LD Micro Invitational - May 30th, 2019 11:50 am
Arch Therapeutics, Inc. $2.8 Million Registered Direct Offering - May 13th, 2019 11:45 am
Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video - Apr 24th, 2019 11:50 am
Arch Therapeutics to Provide Corporate Update at the 31st Annual ROTH Conference - Mar 11th, 2019 11:50 am
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference - Feb 5th, 2019 12:50 pm
Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019 - Dec 20th, 2018 12:50 pm
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel - Dec 17th, 2018 12:50 pm
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event - Dec 6th, 2018 12:50 pm
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court - Dec 4th, 2018 12:50 pm
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe - Nov 28th, 2018 12:50 pm
Arch Therapeutics to Provide Corporate Update at the 11th Annual LD Micro Main Event on Tuesday, December 4, 2018 - Nov 26th, 2018 12:50 pm